A fatal overdose of transdermally administered fentanyl

C Kramer1, M Tawney

  • 1Mount Clemens General Hospital, Department of Emergency Medicine, MI 48043, USA. CKramer% PCS@MCGH.org

Insights

A case study highlights a fatal fentanyl overdose from mucous membrane absorption. A man died from respiratory arrest after using two fentanyl patches, with blood levels significantly exceeding therapeutic ranges.

Area of Science:

  • Toxicology
  • Pharmacology
  • Emergency Medicine

Background:

  • Fentanyl transdermal patches are potent analgesics.
  • Mucous membrane absorption presents a risk for rapid systemic drug delivery.
  • Accidental or intentional misuse of transdermal fentanyl can lead to overdose.

Observation:

  • A 31-year-old male presented with respiratory arrest.
  • Two 75 mcg/h fentanyl transdermal patches were recovered: one from the buccal cavity and one on the thigh.
  • Postmortem venous fentanyl concentration was 17.2 mcg/L, far exceeding the therapeutic range (1-3 mcg/L).

Findings:

  • Buccal mucous membrane absorption of fentanyl from a transdermal patch was identified as a route of exposure.
  • High systemic fentanyl levels correlated with respiratory arrest and death.
  • Co-ingestion of benzodiazepines and cocaine was noted.

Implications:

  • This case underscores the critical danger of fentanyl transdermal patches, especially when misused or placed in the buccal cavity.
  • Healthcare providers must be vigilant for non-traditional routes of fentanyl absorption in overdose cases.
  • Enhanced patient education and secure storage of potent opioids are crucial to prevent such fatalities.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...